Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Antifibrinolytic drugs for acute traumatic injury.

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators.

Cochrane Database Syst Rev. 2012;12:CD004896. Review. Update in: Cochrane Database Syst Rev. 2015;5:CD004896.

PMID:
23418644
2.

Antifibrinolytic drugs for acute traumatic injury.

Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004896. doi: 10.1002/14651858.CD004896.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD004896.

PMID:
21249666
3.

Antifibrinolytic drugs for acute traumatic injury.

Ker K, Roberts I, Shakur H, Coats TJ.

Cochrane Database Syst Rev. 2015 May 9;(5):CD004896. doi: 10.1002/14651858.CD004896.pub4. Review.

PMID:
25956410
4.

Antifibrinolytic drugs for acute traumatic injury.

Coats T, Roberts I, Shakur H.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004896. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD004896.

PMID:
15495129
5.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001886. doi: 10.1002/14651858.CD001886.pub4. Review.

6.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001886. doi: 10.1002/14651858.CD001886.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(3):CD001886.

PMID:
21249650
7.

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Health Technol Assess. 2013 Mar;17(10):1-79. doi: 10.3310/hta17100.

8.

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.

van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE.

Cochrane Database Syst Rev. 2015 Dec 24;(12):CD011385. doi: 10.1002/14651858.CD011385.pub2. Review.

PMID:
26704192
9.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001886. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD001886.

PMID:
17943760
10.

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.

Estcourt LJ, Desborough M, Brunskill SJ, Doree C, Hopewell S, Murphy MF, Stanworth SJ.

Cochrane Database Syst Rev. 2016 Mar 15;3:CD009733. doi: 10.1002/14651858.CD009733.pub3. Review.

11.

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.

Wardrop D, Estcourt LJ, Brunskill SJ, Doree C, Trivella M, Stanworth S, Murphy MF.

Cochrane Database Syst Rev. 2013 Jul 29;(7):CD009733. doi: 10.1002/14651858.CD009733.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD009733.

PMID:
23897323
12.

Methods to decrease blood loss and transfusion requirements for liver transplantation.

Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009052. doi: 10.1002/14651858.CD009052.pub2. Review.

PMID:
22161443
13.

Topical application of tranexamic acid for the reduction of bleeding.

Ker K, Beecher D, Roberts I.

Cochrane Database Syst Rev. 2013 Jul 23;(7):CD010562. doi: 10.1002/14651858.CD010562.pub2. Review.

PMID:
23881695
14.

Tranexamic acid for reducing mortality in emergency and urgent surgery.

Perel P, Ker K, Morales Uribe CH, Roberts I.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD010245. doi: 10.1002/14651858.CD010245.pub2. Review.

PMID:
23440847
15.

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, Sly K, Laupacis A, Fergusson D.

Cochrane Database Syst Rev. 2001;(1):CD001886. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD001886.

PMID:
11279735
16.

Medical interventions for traumatic hyphema.

Gharaibeh A, Savage HI, Scherer RW, Goldberg MF, Lindsley K.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005431. doi: 10.1002/14651858.CD005431.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD005431.

18.

Tranexamic acid for upper gastrointestinal bleeding.

Bennett C, Klingenberg SL, Langholz E, Gluud LL.

Cochrane Database Syst Rev. 2014 Nov 21;(11):CD006640. doi: 10.1002/14651858.CD006640.pub3. Review.

PMID:
25414987
19.

Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.

Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006883. doi: 10.1002/14651858.CD006883.pub2. Review.

PMID:
18646174
20.

Supplemental Content

Support Center